HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Karo Pharma Adds VMS With Deal For Belgium's Sylphar

Executive Summary

Sweden's Karo Pharma is acquiring Sylphar Group and its dietary supplement and beauty brands sold around Europe, primarily online.

You may also be interested in...



Euro Results Round-Up: Karo Pharma And Recordati Post Double-Digit Gains

In the first-half of 2022, Sweden's Karo Pharma saw its sales rise by more than a third thanks to a combination of organic growth and acquisitions. Italy's Recordati reported OTC sales up by almost a fifth as the European market continued to recover post-COVID.

Reckitt Sells Skin-Care Brand E45 To Karo In £200m Deal

Karo Pharma is poised to expand its portfolio in the UK with the acquisition of leading skin-care brand E45 from Reckitt.

EU Q3 Results Round-Up: Karo Pharma, Probi, Ipsen

Round-up of Q3 sales and earnings results for European health and wellness players, featuring Karo Pharma, Probi and Ipsen.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS151979

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel